CSL Limited (ASX:CSL)
Australia · Delayed Price · Currency is AUD 140.78
-0.04 (-0.03%)
At close: Mar 31, 2026
CSL Limited Market Cap
CSL Limited has a market cap or net worth of 67.62 billion as of March 31, 2026. Its market cap has decreased by -44.21% in one year.
Market Cap
67.62B
Enterprise Value
85.30B
Revenue
23.10B
Ranking
n/a
PE Ratio
32.83
Stock Price
140.78
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 312.00M to 67.62B, an increase of 21,572.86%. That is a compound annual growth rate of 18.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 67.60B | -18.79% |
| Dec 31, 2025 | 83.24B | -38.95% |
| Dec 31, 2024 | 136.34B | -1.54% |
| Dec 29, 2023 | 138.48B | -0.20% |
| Dec 30, 2022 | 138.76B | -0.30% |
| Dec 31, 2021 | 139.18B | 8.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 4.63B |
| Mesoblast | 2.72B |
| Neuren Pharmaceuticals | 1.49B |
| Clarity Pharmaceuticals | 1.22B |
| PYC Therapeutics | 1.08B |
| Opthea | 738.77M |
| Clinuvel Pharmaceuticals | 496.99M |
| Racura Oncology | 464.02M |